UNICREDIT BANK/CALL/BIOGEN IDEC/400/0.1/17.12.25 Stock

Warrant

DE000HD1H9N9

Market Closed - Börse Stuttgart 14:18:55 2024-05-17 EDT
1.07 EUR -0.93% Intraday chart for UNICREDIT BANK/CALL/BIOGEN IDEC/400/0.1/17.12.25
Current month+69.84%
1 month+181.58%
Date Price Change
24-05-17 1.07 -0.93%
24-05-16 1.08 -6.90%
24-05-15 1.16 +20.83%
24-05-14 0.96 +3.23%
24-05-13 0.93 +10.71%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 02:18 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD1H9N
ISINDE000HD1H9N9
Date issued 2023-12-28
Strike 400 $
Maturity 2025-12-17 (579 Days)
Parity 10 : 1
Emission price 2
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.01
Lowest since issue 0.2
Delta0.23x
Omega 4.425
Premium78.72x
Gearing19.11x
Moneyness 0.5764
Difference Strike 169.4 $
Difference Strike %+42.36%
Spread 0.02
Spread %1.79%
Theoretical value 1.110
Implied Volatility 38.29 %
Total Loss Probability 88.80 %
Intrinsic value 0.000000
Present value 1.110
Break even 412.07 €
Theta-0.02x
Vega0.08x
Rho0.06x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
230.6 USD
Average target price
285.9 USD
Spread / Average Target
+24.01%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW